{
  "patient_id": "MBC_005",
  "demographics": {
    "age": 62,
    "gender": "female",
    "performance_status": 1
  },
  "diagnosis": {
    "cancer_type": "breast",
    "stage": "metastatic",
    "histology": "invasive_ductal_carcinoma",
    "grade": 3
  },
  "biomarkers": {
    "ER": "negative",
    "PgR": "negative",
    "HER2": "negative",
    "PIK3CA": "wild_type",
    "BRCA1": "wild_type",
    "BRCA2": "wild_type",
    "PALB2": "wild_type",
    "ESR1": "wild_type",
    "PD_L1": "positive",
    "MSI": "high",
    "TMB": 15.3,
    "NTRK": "negative"
  },
  "treatment_history": [
    {
      "line": 1,
      "regimen": "doxorubicin + cyclophosphamide",
      "response": "partial_response",
      "duration_months": 6,
      "progression": true
    },
    {
      "line": 2,
      "regimen": "sacituzumab govitecan",
      "response": "stable_disease",
      "duration_months": 4,
      "progression": true
    }
  ],
  "lab_values": {
    "HbA1c": 6.1,
    "fasting_glucose": 110,
    "creatinine": 0.9,
    "bilirubin": 1.1
  },
  "metastatic_sites": [
    "liver",
    "lung",
    "bone"
  ],
  "contraindications": []
}